Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoxin Chen has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A muscle-enriched mitochondrial protein regulates postnatal heart growth through mitonuclear ubiquinone–PPAR signaling

    by Kentaro Hirose, Xiaoxin Chen, Chakrapani Kalyanaraman, Mark T. Waddingham, Makoto Nakamura, Feng Zhang, Christina Chen, Shun Yao, Steven Chang, Hongyao Yu, et al.

    Increased mitochondrial biogenesis and aerobic respiration in postnatal mammalian organs are essential for adaptation to extrauterine life, yet the functions of many tissue-enriched, developmentally regulated mitochondrial proteins remain poorly defined. By integrating mitochondrial proteome annotations with mouse and human transcriptomic datasets, we identified Coenzyme Q10a (Coq10a), a striated muscle-enriched mitochondrial protein, as a regulator of postnatal cardiac growth. Coq10a, the mammalian homolog of the yeast ubiquinone-binding protein Coq10p, is highly induced in the heart after birth through thyroid hormone-, Nkx2.5-, and Tbx5-dependent regulation. To define its physiological function, we generated three independent Coq10a -deficient mouse models. Both global and cardiomyocyte-specific loss of Coq10a promoted postnatal cardiac hypertrophy without impairing basal cardiac function or mitochondrial respiration. Instead, Coq10a deficiency altered intracellular ubiquinone partitioning, resulting in increased ubiquinone accumulation in a microsomal membrane fraction. Transcriptomic analyses revealed enrichment of PPAR-associated metabolic gene sets and induction of established PPAR-responsive genes in Coq10a -deficient hearts. Pharmacological inhibition of PPARα and PPARγ, but not PPARδ, attenuated the hypertrophic phenotype. Molecular dynamics simulations, docking analyses, and mutagenesis identified PPARα residues that contribute to differential responsiveness to ubiquinone. Although Coq10a -deficient hearts maintained near-normal function under basal conditions, they exhibited increased susceptibility to pressure-overload stress. Together, these findings establish Coq10a as a regulator of intracellular ubiquinone partitioning and support a model linking altered mitochondrial lipid distribution and PPAR-associated signaling to postnatal cardiac growth. More broadly, they demonstrate how tissue-enriched mitochondrial proteins can mediate organ-specific physiological functions beyond energy production.

  • Open Access

    Cell Migration in Tissue Regeneration: Mechanisms, Models, and Therapeutic Opportunities

    by Emma Faye Murry, Marco P. De Leon, Xiaoxin Chen

    Cell migration contributes to tissue homeostasis, repair, and regeneration by controlling the spatial organization of cells within tissues. Although extensively studied in development and wound healing, migration has received comparatively less attention than proliferation and differentiation in regenerative biology. Migrating cells dynamically regulate polarity, cytoskeletal organization, adhesion, extracellular-matrix interactions, guidance sensing, and metabolism and can move individually or collectively. Importantly, migration can be mechanistically separable from proliferation and, in some regenerative contexts, can precede proliferative expansion. In the heart, cardiomyocytes undergo structural remodeling associated with protrusive and migratory behavior, while vascular, immune, and extracellular-matrix responses shape the regenerative environment. In liver and kidney injury, collective cell migration contributes to early wound closure before substantial proliferation, whereas zebrafish fin and axolotl limb regeneration illustrate how cell movement is coordinated with blastema formation and positional information. In this review, we synthesize the molecular and cellular mechanisms regulating migration during tissue homeostasis, repair, and regeneration and compare individual and collective migration across tissues and species, with particular emphasis on cardiac repair and regeneration. We further discuss experimental approaches, therapeutic opportunities, and outstanding questions. We propose that successful regeneration should be viewed not only as a problem of cell proliferation and differentiation but also as a spatial process requiring regenerative cells to reach appropriate locations and integrate into functional tissue architecture.

  • Open Access

    AI-guided ethnopharmacology for cardiovascular drug discovery: from biomedical data to experimental validation

    by Shun Yao, Xiaoxin Chen

    Despite substantial advances in pharmacological therapy, cardiovascular disease remains the leading cause of mortality worldwide. Botanical drugs represent a rich source of structurally diverse bioactive metabolites, yet their translation into modern cardiovascular therapeutics remains limited by chemical complexity, incomplete mechanistic understanding, and challenges in experimental validation. Meanwhile, the rapid expansion of biomedical data resources and advances in artificial intelligence (AI) have created new opportunities to systematically investigate botanical drugs beyond empirical approaches. In this review, we summarize the major biomedical data resources supporting AI-guided ethnopharmacology, including phytochemical and ethnomedicinal databases, multiomics datasets, single-cell and spatial transcriptomics, perturbation-response resources, biological interaction networks, and clinical evidence. We then discuss the computational approaches used for molecular property prediction, drug-target interaction prediction, perturbation-response modeling, and foundation-model transfer learning, highlighting how these complementary strategies address distinct stages of pharmacological discovery. Building on these advances, we propose two complementary AI-guided discovery frameworks: a compound-first strategy that predicts the pharmacological activities of botanical drugs and a disease-first strategy that identifies natural products capable of reversing disease-associated molecular and cellular states. We further discuss emerging applications in cardiovascular diseases, emphasizing the integration of AI with single-cell atlases, disease-state prediction, mechanistic investigation, and experimental validation to prioritize candidate botanical therapeutics. Finally, we outline current challenges in data standardization, model robustness, interpretability, and prospective validation. We propose that AI-guided ethnopharmacology should be viewed as a hypothesis-generation framework that complements, rather than replaces, pharmacological experimentation. When supported by standardized botanical materials, high-quality multimodal data, rigorous biological validation, and prospective clinical evaluation, AI has the potential to accelerate cardiovascular botanical drug discovery and facilitate the translation of ethnomedicinal knowledge into modern precision therapeutics.

  • Open Access

    Chromatin topology control by a muscle-specific ribosomal protein

    by Makoto Nakamura, Xiaoxin Chen, Shun Yao, Lynette Xin Chan, Ruan Hongmei, Alexis Boulinguiez, Nav Lally, Hao Wu, Kara Kodani, Kentaro Hirose, et al.

    Three-dimensional genome organization stabilizes cell-type-specific gene expression, yet the tissue-restricted factors that maintain chromatin insulation remain poorly understood. Here, we identify the muscle-specific ribosomal protein Rpl3l as an unexpected nuclear regulator of genome architecture in atrial cardiomyocytes. Rpl3l is enriched in the nucleus and nucleolus, where it binds its own genomic locus and stabilizes a CTCF-anchored chromatin boundary that represses the T-type calcium channel gene Cacna1h. Loss of Rpl3l weakens local chromatin insulation, increases long-range contacts across the Rpl3l-Cacna1h locus, derepresses Cacna1h, and increases susceptibility to atrial fibrillation (AF), which is suppressed by pharmacological inhibition of T-type calcium channels. Furthermore, AF-associated RPL3L variants exhibit impaired nucleolar localization, reduced rRNA binding, and defective repression of CACNA1H in human iPSC-derived atrial cardiomyocytes. Together, these findings reveal a ribosomal protein-chromatin axis linking genome insulation to ion-channel dosage control and cardiac rhythm stability, expanding the repertoire of cell-type-specific genome architecture regulators.

  • Open Access

    Heart ventricle regeneration in the lizard Eublepharis macularius, the leopard gecko

    by Kathy Jacyniak, Catherine J. A. Williams, Hugues Beaufrère, Jeremy Simpson, Guo N. Huang, Xiaoxin Chen, Matthew K. Vickaryous

    Among mammals, injury to the heart typically results in scar formation and diminished cardiovascular function. In contrast, some teleost fish and salamanders can replace damaged heart tissue and restore overall function. For most species, however, less is known. Here, we investigate cardiac self-repair in an amniote capable of multi-tissue regeneration, the leopard gecko (Eublepharis macularius). To create a heart lesion, we placed a liquid nitrogen-cooled metal probe directly onto the ventricle. The result was a cryoinjury to ~20% of the ventricle. Cardiac cryoinjury induced localized cardiac cell death, followed by an increase in cell proliferation by injury-adjacent cardiomyocytes and non-cardiomyocytes. By 100 days, the histology of the ventricular myocardium was nearly completely restored. Echocardiography and invasive hemodynamic monitoring demonstrated that global cardiac function is restored within this timeframe, verifying functional replacement of the myocardium. To explore the molecular basis, we performed bulk RNA sequencing of the injury-adjacent tissue and found that many of the molecular mechanisms common to other cardiac regenerating species, including genes involved in heart development, glycolysis, and extracellular matrix deposition, are also conserved in geckos. Taken together, this work expands the comparative framework of heart regeneration to include reptiles and indicates that the ability to replace missing or damaged cardiomyocytes is shared across >50 million years of evolution.

  • Open Access

    A transcription regulator atlas identifies TOX3 as an Atoh1 coactivator in cerebellar development and tumorigenesis

    by Xiaoxin Chen, Xiaochen Zhong, William Yue, Bruce Wang, Brian Woo, Hani Goodarzi, Zaili Luo, Q. Richard Lu, Frédéric Flamant, Jeremy F. Reiter, et al.

    Organ development and function are orchestrated by intricate transcriptional circuits. Here, we present a comprehensive atlas profiling 1,904 transcription regulators in the brain, cerebellum, heart, kidney, liver, ovary, and testis of fetal, neonatal, and adult mice. Using this dataset, we uncover Thymocyte Selection-Associated High Mobility Group Box Family Member 3 (TOX3) as a potential coactivator of Atoh1 in cerebellar granule neuron progenitors (GNPs). Tox3 -deficient mice display severe ataxia and cerebellar hypoplasia, driven by depletion of GNPs, diminished Atoh1 expression, and impaired primary cilia. Single-nucleus RNA-sequencing analyses reveals compromised maintenance of the progenitor pool. TOX3 is also highly expressed in subsets of medulloblastoma, and its deletion reduces cerebellar neoplasia and prolongs survival in a mouse model. Mechanistically, how lineage-defining factors such as Atoh1 drive robust gene expression despite weak intrinsic transactivation activity remains unclear. We show that Tox3 physically associates with Atoh1 and co-occupies shared regulatory elements, converting an otherwise weak single-copy Atoh1-responsive E-box into a highly active enhancer that drives transcriptional activation by up to 120-fold, including at an ultraconserved E-box downstream of Atoh1 itself. Cross-species single-cell comparisons further show an association between Tox3 expression and cerebellum expansion during vertebrate evolution. Together, this work supports Tox3 as a critical Atoh1 coactivator in cerebellar development, tumorigenesis, and evolution, while providing an atlas and screening strategy as a valuable resource for exploring novel transcriptional regulators in organogenesis and tissue physiology.


  • Open Access

    CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation

    by Siqi Chen, Yingyu Wang, Jessica Dang, Nuozi Song, Xiaoxin Chen, Jinhui Wang, Guo N. Huang, Christine E. Brown, Jianhua Yu, Irving L. Weissman, et al.

    Macrophage-based cancer cellular therapy has gained substantial interest. However, the capability of engineered macrophages to target cancer heterogeneity and modulate adaptive immunity remains unclear. Here, exploiting the myeloid antibody-dependent cellular phagocytosis biology and phagocytosis checkpoint blockade, we report the enhanced synthetic phagocytosis receptor (eSPR) that integrate FcRγ-driven phagocytic chimeric antigen receptors (CAR) with built-in secreted CD47 blockers. The eSPR engineering empowers macrophages to combat tumor antigen heterogeneity. Transduced by adenoviral vectors, eSPR macrophages are intrinsically pro-inflammatory imprinted and resist tumoral polarization. Transcriptomically and phenotypically, eSPR macrophages elicit a more favorable tumor immune landscape. Mechanistically, eSPR macrophages in situ stimulate CD8 T cells via phagocytosis-dependent antigen cross-presentation. We also validate the functionality of the eSPR system in human primary macrophages.


  • Open Access

    Heart regeneration from the whole-organism perspective to single-cell resolution

    by Xiaoxin Chen, Xiaochen Zhong, Guo N. Huang

    Cardiac regenerative potential in the animal kingdom displays striking divergence across ontogeny and phylogeny. Here we discuss several fundamental questions in heart regeneration and provide both a holistic view of heart regeneration in the organism as a whole, as well as a single-cell perspective on intercellular communication among diverse cardiac cell populations. We hope to provide valuable insights that advance our understanding of organ regeneration and future therapeutic strategies.


  • Open Access

    An injury-responsivemmp14benhancer is required for heart regeneration

    by Ivana Zlatanova, Fei Sun, Roland S. Wu, Xiaoxin Chen, Bryan H. Lau, Pauline Colombier, Tanvi Sinha, Barbara Celona, Shan-Mei Xu, Stefan C. Materna, et al.

    Mammals have limited capacity for heart regeneration, whereas zebrafish have extraordinary regeneration abilities. During zebrafish heart regeneration, endothelial cells promote cardiomyocyte cell cycle reentry and myocardial repair, but the mechanisms responsible for promoting an injury microenvironment conducive to regeneration remain incompletely defined. Here, we identify the matrix metalloproteinase Mmp14b as an essential regulator of heart regeneration. We identify a TEAD-dependentmmp14bendothelial enhancer induced by heart injury in zebrafish and mice, and we show that the enhancer is required for regeneration, supporting a role for Hippo signaling upstream ofmmp14b. Last, we show that MMP-14 function in mice is important for the accumulation of Agrin, an essential regulator of neonatal mouse heart regeneration. These findings reveal mechanisms for extracellular matrix remodeling that promote heart regeneration.